| Schedule of Changes in Stockholders’ Equity |
The
following are changes in stockholders’ (deficit) equity for the six months ended June 30, 2026 and 2025:
Schedule of Changes in Stockholders’ Equity
| | |
Shares | | |
Amount | | |
Capital | | |
(Deficit) | | |
Total | |
| | |
Common Stock | | |
Additional
paid in | | |
Accumulated | | |
| |
| | |
Shares | | |
Amount | | |
Capital | | |
(Deficit) | | |
Total | |
| | |
| | |
| | |
| | |
| | |
| |
| Balance December 31, 2024 | |
| 14,746,172 | | |
$ | - | | |
$ | 64,199,000 | | |
$ | (63,621,000 | ) | |
$ | 578,000 | |
| Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding | |
| 141,296 | | |
| - | | |
| (161,000 | ) | |
| - | | |
| (161,000 | ) |
| Shares issued in settlement of former Arps shareholder and manager notes | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| Issuance of detachable warrants | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| Equity-based compensation expense | |
| - | | |
| - | | |
| 297,000 | | |
| - | | |
| 297,000 | |
| Registered issuance of common stock | |
| 1,052,793 | | |
| - | | |
| 2,974,000 | | |
| - | | |
| 2,974,000 | |
| Net loss | |
| - | | |
| - | | |
| - | | |
| (1,641,000 | ) | |
| (1,641,000 | ) |
| Balance June 30, 2025 | |
| 15,940,261 | | |
$ | - | | |
$ | 67,309,000 | | |
$ | (65,262,000 | ) | |
$ | 2,047,000 | |
| | |
Common Stock | | |
Additional
paid in | | |
Accumulated | | |
| |
| | |
Shares | | |
Amount | | |
Capital | | |
(Deficit) | | |
Total | |
| | |
| | |
| | |
| | |
| | |
| |
| Balance December 31, 2025 | |
| 15,969,281 | $ | |
| - | | |
$ | 67,645,000 | | |
$ | (66,315,000 | ) | |
$ | 1,330,000 | |
| Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding | |
| 103,307 | | |
| - | | |
| (55,000 | ) | |
| - | | |
| (55,000 | ) |
| Equity-based compensation expense | |
| - | | |
| - | | |
| 256,000 | | |
| - | | |
| 256,000 | |
| Shares issued in settlement of former Arps shareholder and manager notes | |
| 135,572 | | |
| - | | |
| 420,000 | | |
| - | | |
| 420,000 | |
| Issuance of detachable warrants | |
| - | | |
| - | | |
| 487,000 | | |
| | | |
| 487,000 | |
| Net loss | |
| - | | |
| - | | |
| - | | |
| (2,522,000 | ) | |
| (2,522,000 | ) |
| Balance June 30, 2026 | |
| 16,208,160 | $ | |
| - | | |
$ | 68,753,000 | | |
$ | (68,837,000 | ) | |
$ | (84,000 | ) |
|
| Schedule of Stock Options Activity |
The
following is a summary of stock option activity for the six months ended June 30, 2026:
Schedule of Stock Options Activity
| | |
Number of Options | | |
Weighted average exercise price per share | | |
Remaining term in years | |
| Outstanding on December 31, 2025 | |
| 763,002 | | |
$ | 4.60 | | |
| 5.3 | |
| Granted | |
| 29,030 | | |
$ | 2.62 | | |
| 8.0 | |
| Forfeited | |
| (22,831 | ) | |
$ | 2.53 | | |
| | |
| Outstanding on June 30, 2026 | |
| 769,201 | | |
$ | 4.59 | | |
| 4.8 | |
| | |
| | | |
| | | |
| | |
| Exercisable, June 30, 2026 | |
| 616,932 | | |
$ | 5.06 | | |
| 3.9 | |
|
| Schedule of Restricted Stock Award and Restricted Stock Unit Activity |
The
following is a summary of restricted stock award and restricted stock unit activity for the six months ended June 30, 2026:
Schedule of Restricted Stock Award and Restricted Stock Unit Activity
| | |
Number of
shares | | |
Weighted average grant date fair value | |
| Unvested at December 31, 2025 | |
| 148,554 | | |
$ | 2.75 | |
| Granted | |
| 24,251 | | |
$ | 2.41 | |
| Vested | |
| (67,622 | ) | |
$ | 2.49 | |
| Forfeited | |
| - | | |
$ | - | |
| Unvested at June 30, 2026 | |
| 105,183 | | |
$ | 2.84 | |
|